Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0106267001
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Cancelled Post Market | 00083259 | CUTTER MED & BIOL, DIVISION OF MILES CANADA LTD. | GAMASTAN | Human | No | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 16.5 % |
Marketed | 02486598 | GRIFOLS THERAPEUTICS LLC | GAMASTAN | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 18 % |
Cancelled Post Market | 02230579 | GRIFOLS THERAPEUTICS LLC | GAMASTAN S/D | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 18 % |
Cancelled Post Market | 01915312 | ARMOUR PHARMACEUTICAL CO. | GAMMAR INJ 165MG/ML | Human | No | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 165 MG / ML |
Cancelled Post Market | 02230647 | GRIFOLS THERAPEUTICS LLC | IMMUNE SERUM GLOBULIN (HUMAN) | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 18 % |
Application information
Related information
Contact us
Version 4.0.3